Literature DB >> 21486383

Genetic variants of F11, statin use and venous thrombosis.

L A Bare, A R Arellano, C H Tong, I Bezemer, W M Lijfering, J J Devlin, P H Reitsma, F R Rosendaal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21486383     DOI： 10.1111/j.1538-7836.2011.04289.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

1.  The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.

Authors:  Ari Allyn-Feuer; Alex Ade; Jasmine A Luzum; Gerald A Higgins; Brian D Athey
Journal:  Pharmacogenomics       Date:  2018-02-05       Impact factor: 2.533

Review 2.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

3.  The association of F11 genetic variants with the risk of incident venous thrombosis among women, by statin use.

Authors:  Laura B Harrington; Kerri L Wiggins; Colleen M Sitlani; Marc Blondon; Astrid van Hylckama Vlieg; Frits R Rosendaal; Susan R Heckbert; Bruce M Psaty; Nicholas L Smith
Journal:  Thromb Haemost       Date:  2015-12-03       Impact factor: 5.249
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.